GeneLink Posts $2M in Q2 Revenues, Narrows Loss | GenomeWeb

NEW YORK (GenomeWeb News) – GeneLink today reported that its second-quarter revenues increased to $2.1 million from $125,000 in the same quarter of 2008.

The company said that virtually all of its revenue came from sales of its LifeMap line of skin care and nutrition formulations based on customers' genetic makeup. GeneLink sells these products through its GeneWize Life Sciences business, which was launched last August.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.